E. Kajiwara

发表

Valuable antiviral therapeutic options for the treatment of chronic hepatitis C patients with thrombocytopenia

J. Hayashi, H. Ikezaki, N. Furusyo, 2013, Journal of viral hepatitis.

Tenofovir alafenamide after switching from entecavir or nucleos(t)ide combination therapy for patients with chronic hepatitis B

H. Nomura, J. Hayashi, N. Furusyo, 2020, Liver international : official journal of the International Association for the Study of the Liver.

Inhibition of emotional needs and emotional wellbeing predict disease progression of chronic hepatitis C patients: an 8-year prospective study

J. Nagano, N. Sudo, T. Hiramoto, 2016, BioPsychoSocial Medicine.

Influence of low-density lipoprotein cholesterol on virological response to telaprevir-based triple therapy for chronic HCV genotype 1b infection.

H. Nomura, J. Hayashi, K. Kotoh, 2014, Antiviral research.

Body surface area is an independent factor contributing to the effects of lamivudine treatment.

H. Nomura, J. Hayashi, K. Kotoh, 2005, Hepatology research : the official journal of the Japan Society of Hepatology.

Switching to tenofovir alafenamide for nucleos(t)ide analogue‐experienced patients with chronic hepatitis B: week 144 results from a real‐world, multi‐centre cohort study

H. Nomura, J. Hayashi, N. Furusyo, 2022, Alimentary pharmacology & therapeutics.

Short‐term risk of hepatocellular carcinoma after hepatitis C virus eradication following direct‐acting anti‐viral treatment

H. Nomura, J. Hayashi, N. Furusyo, 2018, Alimentary pharmacology & therapeutics.

Hepatocarcinogenesis in chronic hepatitis C patients achieving a sustained virological response to interferon: significance of lifelong periodic cancer screening for improving outcomes

K. Kotoh, E. Kajiwara, N. Yamashita, 2014, Journal of Gastroenterology.

Significance of hepatic resection for hepatocellular carcinoma with sustained virological response to interferon therapy for chronic hepatitis C

K. Mimori, K. Sugimachi, H. Higashi, 2013, Hepatology research : the official journal of the Japan Society of Hepatology.

Telaprevir can be successfully and safely used to treat older patients with genotype 1b chronic hepatitis C.

H. Nomura, J. Hayashi, K. Kotoh, 2013, Journal of hepatology.

Tumor lysis syndrome after sorafenib for hepatocellular carcinoma

M. Kinjo, E. Kajiwara, N. Yamashita, 2014 .

Effectiveness and safety of sofosbuvir plus ribavirin for HCV genotype 2 patients 65 and over with or without cirrhosis.

H. Nomura, J. Hayashi, N. Furusyo, 2016, Antiviral research.

Effectiveness of triple therapy with simeprevir for chronic hepatitis C genotype 1b patients with prior telaprevir failure

H. Nomura, J. Hayashi, K. Kotoh, 2015, Journal of viral hepatitis.

NS5A resistance-associated variants undermine the effectiveness of ledipasvir and sofosbuvir for cirrhotic patients infected with HCV genotype 1b

H. Nomura, J. Hayashi, N. Furusyo, 2017, Journal of Gastroenterology.

Effectiveness and safety of daclatasvir plus asunaprevir for patients with hepatitis C virus genotype 1b aged 75 years and over with or without cirrhosis

H. Nomura, J. Hayashi, K. Kotoh, 2016, Hepatology research : the official journal of the Japan Society of Hepatology.

Comparative effectiveness and safety study of triple therapy with simeprevir or telaprevir for non‐cirrhotic patients with chronic hepatitis C virus genotype 1b infection

H. Nomura, J. Hayashi, K. Kotoh, 2015, Journal of gastroenterology and hepatology.

HCV Cure Rates are Reduced in Patients with Active but not Inactive Hepatocellular Carcinoma- A Practice Implication.

H. Nomura, J. Hayashi, Hwai I. Yang, 2019, Clinical Infectious Diseases.

Adult T-cell leukemia/lymphoma in which the pathohistological diagnosis was identical to that of Ki-1 positive anaplastic large cell lymphoma.

Y. Sasaguri, K. Masutani, S. Sadoshima, 1999, Internal medicine.

Prevalence and long-term prognosis of mild hypertensives and hypertensives in a Japanese community, Hisayama.

M. Fujishima, Y. Kiyohara, T. Omae, 1988, Journal of hypertension.

Comparative safety study on severe anemia by simeprevir versus telaprevir‐based triple therapy for chronic hepatitis C

H. Nomura, J. Hayashi, K. Kotoh, 2015, Journal of gastroenterology and hepatology.

Effectiveness of biweekly low‐dosage peginterferon treatment on the improvement of serum alanine aminotransferase and α‐fetoprotein levels

E. Kajiwara, N. Yamashita, Aritune Ooho, 2012, Hepatology research : the official journal of the Japan Society of Hepatology.

Decreased expression of intestinal chemokine TECK/CCL25 in experimental obstructive jaundice and its reversal following internal biliary drainage

Y. Ku, M. Miyazawa, T. Ajiki, 2008, Journal of Gastroenterology.

Infection of Adult Thymus with Murine Retrovirus Induces Virus-Specific Central Tolerance That Prevents Functional Memory CD8+ T Cell Differentiation

M. Itoi, M. Miyazawa, S. Takamura, 2014, PLoS pathogens.

Prevalences of hepatitis B surface antigen carriers and liver damages in the general population of Hisayama, Japan.

M. Fujishima, Y. Kiyohara, I. Kato, 1992, Fukuoka igaku zasshi = Hukuoka acta medica.

Transient cerebral ischemic attacks in a Japanese community, Hisayama, Japan.

M. Fujishima, Y. Kiyohara, T. Omae, 1987, Stroke.

Telaprevir‐based triple therapy for chronic hepatitis C patients with advanced fibrosis: a prospective clinical study

H. Nomura, J. Hayashi, K. Kotoh, 2013, Alimentary pharmacology & therapeutics.

An inadequate dose of ribavirin is related to virological relapse by chronic hepatitis C patients treated with pegylated interferon alpha-2b and ribavirin

H. Nomura, J. Hayashi, K. Kotoh, 2012, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

Elbasvir plus grazoprevir for patients with chronic hepatitis C genotype 1: A multicenter, real‐world cohort study focusing on chronic kidney disease

H. Nomura, J. Hayashi, N. Furusyo, 2018, Antiviral research.

Long‐term hepatic function of patients with compensated cirrhosis following successful direct‐acting antiviral treatment for hepatitis C virus infection

H. Nomura, J. Hayashi, N. Furusyo, 2021, Journal of gastroenterology and hepatology.

Efficacy and safety of splenectomy in telaprevir‐based triple therapy for chronic hepatitis C patients with thrombocytopenia and advanced fibrosis

H. Nomura, J. Hayashi, Y. Maehara, 2014, Journal of gastroenterology and hepatology.

Persistence of Viremia and Production of Neutralizing Antibodies Differentially Regulated by Polymorphic APOBEC3 and BAFF-R Loci in Friend Virus-Infected Mice

M. Miyazawa, S. Takamura, Maiko Kato, 2010, Journal of Virology.

Systemic Lupus Erythematosus After α-Interferon Therapy for Chronic Hepatitis C: A Case Report and Review of the Literature

S. Fukuyama, S. Sadoshima, E. Kajiwara, 2000, American Journal of Gastroenterology.

Factors contributing to ribavirin‐induced anemia

H. Nomura, S. Kashiwagi, J. Hayashi, 2004, Journal of gastroenterology and hepatology.

Bacterial infection as an adverse effect of telaprevir-based triple therapy for chronic hepatitis C infection.

H. Nomura, J. Hayashi, K. Kotoh, 2015, Internal medicine.

Effects of lamivudine on serum albumin levels correlate with pretreatment HBV-DNA levels in cirrhotic patients

H. Nomura, J. Hayashi, K. Kotoh, 2007, Comparative hepatology.

A significant reduction in serum alanine aminotransferase levels after 3-month iron reduction therapy for chronic hepatitis C: a multicenter, prospective, randomized, controlled trial in Japan

M. Sata, T. Okanoue, Y. Niitsu, 2004, Journal of Gastroenterology.

Thyroid function in "yusho" patients exposed to polychlorinated biphenyls (PCB).

M. Fujishima, K. Okamura, H. Tsuji, 1987, Environmental research.

Association between the treatment length and cumulative dose of pegylated interferon alpha‐2b plus ribavirin and their effectiveness as a combination treatment for Japanese chronic hepatitis C patients: Project of the Kyushu University Liver Disease Study Group

H. Nomura, J. Hayashi, N. Furusyo, 2008, Journal of gastroenterology and hepatology.

Intramural duodenal hematoma after endoscopic therapy for a bleeding duodenal ulcer in a patient with liver cirrhosis.

E. Kajiwara, Y. Mochizuki, E. Noma, 2005, Internal medicine.

Role of bursin in the development of B lymphocytes in chicken embryonic Bursa of Fabricius.

H. Matsuda, H. Horiuchi, S. Furusawa, 2001, Developmental and comparative immunology.

Relationship between body surface area and ALT normalization after long-term lamivudine treatment.

H. Nomura, J. Hayashi, K. Kotoh, 2005, World journal of gastroenterology.

Immunobiology of chicken germinal center: I. Changes in surface Ig class expression in the chicken splenic germinal center after antigenic stimulation.

M. Yasuda, Y. Taura, H. Matsuda, 2003, Developmental and comparative immunology.

(免疫学)ニワトリ胚におけるバイエル氏板,盲腸扁桃(腸管付属リンパ組織)の発生

H. Matsuda, A. Shigeta, H. Horiuchi, 2003 .

Development of Peyer's patch and cecal tonsil in gut-associated lymphoid tissues in the chicken embryo.

H. Matsuda, A. Shigeta, H. Horiuchi, 2003, The Journal of veterinary medical science.

[A case of autoimmune hepatitis with high IgM class smooth muscle antibody and systemic vascular disease].

M. Fujishima, H. Tsuji, E. Kajiwara, 1987, Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology.

Hepatitis B caused by a hepatitis B surface antigen escape mutant

T. Ohashi, M. Mizokami, Yasuhito Tanaka, 2008, Journal of Gastroenterology.

Importance of virological response in the early stage of telaprevir-based triple therapy for hepatitis C.

H. Nomura, J. Hayashi, K. Kotoh, 2015, World journal of hepatology.

Long-term lamivudine treatment for chronic hepatitis B in Japanese patients: a project of Kyushu University Liver Disease Study.

H. Nomura, J. Hayashi, N. Furusyo, 2006, World journal of gastroenterology.

Sequential HBV treatment with tenofovir alafenamide for patients with chronic hepatitis B: week 96 results from a real-world, multicenter cohort study

H. Nomura, J. Hayashi, N. Furusyo, 2021, Hepatology International.

Parallel evolution in radiation ofOhomopterus ground beetles inferred from mitochondrial ND5 gene sequences

T. Ohama, S. Osawa, Keiko Nakamura, 1996, Journal of Molecular Evolution.

Hepatocellular carcinoma manifested as pyogenic liver abscess: A case report

M. Kinjo, E. Kajiwara, N. Yamashita, 2015 .

Differential hepatic distribution of insulin receptor substrates causes selective insulin resistance in diabetes and obesity

T. Noda, Y. Terauchi, T. Kadowaki, 2016, Nature Communications.

Evaluation of the adverse effect of premature discontinuation of pegylated interferon α‐2b and ribavirin treatment for chronic hepatitis C virus infection: Results from Kyushu University Liver Disease Study

H. Nomura, J. Hayashi, K. Kotoh, 2012, Journal of gastroenterology and hepatology.

Interferon alpha plus ribavirin combination treatment of Japanese chronic hepatitis C patients with HCV genotype 2: a project of the Kyushu University Liver Disease Study Group.

H. Nomura, J. Hayashi, N. Furusyo, 2006, World journal of gastroenterology.

Glecaprevir and pibrentasvir for Japanese patients with chronic hepatitis C genotype 1 or 2 infection: Results from a multicenter, real‐world cohort study

H. Nomura, J. Hayashi, N. Furusyo, 2019, Hepatology research : the official journal of the Japan Society of Hepatology.

Efficacy of pegylated interferon alpha-2b and ribavirin treatment on the risk of hepatocellular carcinoma in patients with chronic hepatitis C: a prospective, multicenter study.

H. Nomura, J. Hayashi, K. Kotoh, 2013, Journal of hepatology.

Genome-Wide Association Study Identifies TLL1 Variant Associated With Development of Hepatocellular Carcinoma After Eradication of Hepatitis C Virus Infection.

H. Yoshiji, K. Ikeo, N. Enomoto, 2017, Gastroenterology.

Protection of Macaques with Diverse MHC Genotypes against a Heterologous SIV by Vaccination with a Deglycosylated Live-Attenuated SIV

Y. Nagai, A. Kimura, Yasuo Suzuki, 2010, PloS one.

Cost-effectiveness analysis of sofosbuvir plus ribavirin in patients with genotype 2 chronic hepatitis C: an analysis with real world outcomes from a multicentre cohort in Japan

H. Nomura, J. Hayashi, N. Furusyo, 2019, BMJ Open.

Pegylated interferon α-2b plus ribavirin for older patients with chronic hepatitis C.

H. Nomura, J. Hayashi, K. Kotoh, 2010, World journal of gastroenterology.

Ileal varices associated with recurrent bleeding in a patient with liver cirrhosis

Y. Sasaguri, E. Kajiwara, N. Suzuki, 1999, Journal of Gastroenterology.

Long‐term assessment of recurrence of hepatocellular carcinoma in patients with chronic hepatitis C after viral cure by direct‐acting antivirals

H. Nomura, J. Hayashi, N. Furusyo, 2021, Journal of gastroenterology and hepatology.

TCF7L2 in mouse pancreatic beta cells plays a crucial role in glucose homeostasis by regulating beta cell mass

T. Kadowaki, T. Kitamura, N. Kubota, 2014, Diabetologia.

Clinical milestones for the prediction of severe anemia by chronic hepatitis C patients receiving telaprevir-based triple therapy.

H. Nomura, J. Hayashi, K. Kotoh, 2013, Journal of hepatology.

Repeat hepatectomies for hepatic malignant lymphoma and hepatocellular carcinoma associated with chronic hepatitis C: report of a case

K. Sugimachi, T. Shimokama, H. Higashi, 2013, Surgery Today.

Genome-Wide Association Study Identi fi es TLL 1 Variant Associated With Development of Hepatocellular Carcinoma After Eradication of Hepatitis C Virus Infection

H. Yoshiji, K. Ikeo, N. Enomoto, 2017 .

Development of hepatocellular carcinoma after seroclearance of hepatitis surface antigen

T. Shimokama, H. Higashi, M. Kinjo, 2011 .

Inhibition of hepatocellular carcinoma by PegIFNα-2a in patients with chronic hepatitis C: a nationwide multicenter cooperative study

M. Kudo, K. Chayama, M. Kurosaki, 2012, Journal of Gastroenterology.

Development of Hepatocellular Carcinoma in Patients Aged 75–84 Years With Chronic Hepatitis C Treated With Direct-Acting Antivirals

H. Nomura, J. Hayashi, N. Furusyo, 2020, The Journal of infectious diseases.

Pegylated interferon α‐2b plus ribavirin for Japanese chronic hepatitis C patients with normal alanine aminotransferase

H. Nomura, J. Hayashi, K. Kotoh, 2012, Hepatology research : the official journal of the Japan Society of Hepatology.

Increased liver temperature efficiently augments human cellular immune response: T-cell activation and possible monocyte translocation

V. Ostapenko, M. Ichinose, M. Miyazawa, 2006, Cancer Immunology, Immunotherapy.

Ledipasvir and sofosbuvir for 12 weeks for hepatitis C virus genotype 2 infection: A propensity score matched analysis

H. Nomura, J. Hayashi, N. Furusyo, 2020, Hepatology research : the official journal of the Japan Society of Hepatology.

Raloxifene hydrochloride is an adjuvant antiviral treatment of postmenopausal women with chronic hepatitis C: a randomized trial.

J. Hayashi, H. Ikezaki, N. Furusyo, 2012, Journal of hepatology.

Evidence for an immunological pathogenesis of thrombocytopenia in chronic liver disease.

M. Fujishima, K. Azuma, E. Kajiwara, 1995, The American journal of gastroenterology.

Efficacy of prolonged treatment following combination with ribavirin and interferon for chronic hepatitis type C: A pilot study.

H. Nomura, S. Kashiwagi, J. Hayashi, 2005, Hepatology research : the official journal of the Japan Society of Hepatology.

Incidence of Hepatocellular Carcinoma after Treatment with Sofosbuvir-Based or Sofosbuvir-Free Regimens in Patients with Chronic Hepatitis C

H. Nomura, J. Hayashi, N. Furusyo, 2020, Cancers.

[A case of asymptomatic primary biliary cirrhosis associated with multiple myeloma and atrophic thyroiditis].

M. Fujishima, M. Washio, K. Okamura, 1987, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine.

An elderly autoimmune hepatitis patient with a fulminant course

M. Kinjo, E. Kajiwara, N. Yamashita, 2014 .

HCC risk post-SVR with DAAs in East Asians: findings from the REAL-C cohort

H. Nomura, J. Hayashi, Hwai I. Yang, 2020, Hepatology International.

Low activity of gamma-glutamyl transpeptidase in serum of acute intrahepatic cholestasis.

M. Fujishima, H. Tsuji, E. Kajiwara, 1991, Enzyme.

[Thyroid function in patients with PCB poisoning].

M. Fujishima, H. Tsuji, E. Kajiwara, 1985, Fukuoka igaku zasshi = Hukuoka acta medica.

Systemic lupus erythematosus after alpha-interferon therapy for chronic hepatitis C: a case report and review of the literature.

S. Fukuyama, S. Sadoshima, E. Kajiwara, 2000, The American journal of gastroenterology.